Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-17.30 Insider Own2.70% Shs Outstand1.02B Perf Week-3.70%
Market Cap20.52B Forward P/E7.06 EPS next Y2.84 Insider Trans-0.02% Shs Float975.55M Perf Month-2.58%
Income-17586.00M PEG- EPS next Q0.67 Inst Own60.30% Short Float6.73% Perf Quarter50.34%
Sales22.39B P/S0.92 EPS this Y-38.90% Inst Trans8.09% Short Ratio2.85 Perf Half Y21.53%
Book/sh13.51 P/B1.48 EPS next Y15.89% ROA-19.80% Target Price18.73 Perf Year-44.05%
Cash/sh0.96 P/C20.94 EPS next 5Y-5.43% ROE-70.70% 52W Range10.85 - 36.19 Perf YTD5.75%
Dividend0.85 P/FCF11.85 EPS past 5Y-57.50% ROI-36.00% 52W High-44.63% Beta0.56
Dividend %4.24% Quick Ratio0.60 Sales past 5Y2.00% Gross Margin48.40% 52W Low84.70% ATR1.01
Employees51800 Current Ratio0.90 Sales Q/Q-15.90% Oper. Margin-78.10% RSI (14)50.61 Volatility3.27% 4.65%
OptionableYes Debt/Eq2.37 EPS Q/Q- Profit Margin-73.80% Rel Volume0.32 Prev Close19.80
ShortableYes LT Debt/Eq2.10 EarningsFeb 08 BMO Payout- Avg Volume23.04M Price20.04
Recom3.10 SMA20-0.76% SMA502.06% SMA200-5.82% Volume7,265,872 Change1.21%
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
Jan-26-18Reiterated Leerink Partners Underperform $15 → $17
Jan-25-18Reiterated Susquehanna Positive $22 → $24
Jan-18-18Downgrade BTIG Research Buy → Neutral
Jan-09-18Upgrade Mizuho Neutral → Buy $23
Jan-05-18Downgrade Wells Fargo Market Perform → Underperform
Jan-04-18Upgrade Citigroup Neutral → Buy
Jan-03-18Initiated Leerink Partners Underperform $15
Dec-15-17Upgrade Morgan Stanley Underweight → Equal-Weight
Dec-15-17Upgrade Goldman Neutral → Buy
Dec-15-17Upgrade Credit Suisse Underperform → Neutral
Dec-12-17Initiated Guggenheim Neutral $16
Nov-29-17Reiterated Mizuho Neutral $12 → $16
Nov-17-17Reiterated Mizuho Neutral $15 → $12
Nov-13-17Downgrade JP Morgan Neutral → Underweight
Nov-07-17Downgrade HSBC Securities Hold → Reduce
Feb-23-18 06:23PM  Berkshire's 4th Quarter Buy Teva Appears Cheap and Troubled GuruFocus.com
06:26AM  Healthcare: Warren Buffett's Surprising New Buy Motley Fool
Feb-21-18 08:13AM  Teva's Problems Continue to Mount With No Relief in Sight Zacks
Feb-20-18 11:33PM  Trial Tests FTCs Power to Referee Drug Makers Fight Against Generics The Wall Street Journal
05:09PM  Outside Of Apple, Here Are 6 Other Stocks Warren Buffett Bought In Q4 Benzinga
11:59AM  Outside Of Apple, Here Are 6 Other Stocks Warren Buffett Bought In Q4 Harvest Exchange
11:03AM  Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn® in the United States Business Wire
08:15AM  3 Big Stocks That Slashed Their Dividends in 2017 Motley Fool
08:00AM  Trial Tests FTC's Power to Referee Drugmakers' Fight Against Generics The Wall Street Journal
07:34AM  6 Reasons Buffett Bought Into Teva Pharmaceutical, as Told by a Teva Shareholder Motley Fool
Feb-16-18 03:16PM  United Therapeutics settles patent litigation over $157M drug American City Business Journals
01:55PM  Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles TheStreet.com
12:50PM  Francis Chou Nearly Dumps Entire Stake in Valeant, Teva and Overstock in 4th Quarter GuruFocus.com
11:39AM  Teva Announces U.S. Launch of QVAR® RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol Business Wire
10:25AM  Teva Stock Spikes After 13F Filing of Buffett's Berkshire Is Revealed Investopedia
08:10AM  Todays Research Reports on Stocks to Watch: Ironwood Pharmaceuticals and Teva Pharmaceutical ACCESSWIRE
06:04AM  Why in the World Does Warren Buffett Like Teva Pharmaceutical? Motley Fool
Feb-15-18 05:24PM  After the Bell: Dow Soars 300 Points as Utilities Lead Stocks Higher Barrons.com +7.66%
05:11PM  Top Stocks Warren Buffett Is Buying Now Motley Fool
05:07PM  Three Stocks Are Advancing GuruFocus.com
04:39PM  Cisco Systems and Teva jump while NetApp slumps Associated Press
04:34PM  Why Teva Pharmaceutical Industries, SolarEdge Technologies, and Overstock.com Jumped Today Motley Fool
04:10PM  Dow Jumps Over 300 Points, Posting Its Fifth Straight Day of Gains TheStreet.com
04:05PM  Here's What Warren Buffett, Other Top Investors Are Buying And Selling Investor's Business Daily
03:07PM  Buffett Bails on IBM While Taking Teva Stake Bloomberg Video
03:06PM  Buffett Bails on IBM While Taking Teva Stake Bloomberg
02:32PM  CNBC IQ 100: Teva Pharma up nearly 8% CNBC Videos
12:05PM  Jana Partners Bought Facebook, Comcast and Teva: 13F Filings Investopedia
11:36AM  Why Warren Buffett's Berkshire Hathaway loves loathed Israeli drug stock Teva CNBC
11:23AM  Cramer: I'm shocked by Buffett's Berkshire making a bet on worst-of-the-worst Teva CNBC
11:08AM  Here's Why Teva Pharma Stock Is Soaring Today Zacks
10:57AM  Cramer: I'm shocked by Buffett's Berkshire making a bet o... CNBC Videos
10:10AM  Teva's stock soars after Warren Buffett's Berkshire discloses new stake MarketWatch
09:02AM  Apple, Teva rip higher on Buffett's Berkshire investments CNBC
08:02AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:10AM  S&P 500, Dow, Nasdaq Futures Rise: This Top Tech Stock Is Set To Break Out On Earnings Investor's Business Daily
06:34AM  Teva Is Drowning in Debt and Firing Thousands of Employees. Now Warren Buffett Is Interested Fortune
05:35AM  Buffett's Berkshire Hathaway Adds Apple and Teva Shares, Dumps IBM Investopedia
03:46AM  Teva Surges as Buffett's Investment Stokes Hopes of Recovery Bloomberg
Feb-14-18 08:15PM  GM, Teva, Facebook and Other New Jana Partners Positions TheStreet.com
07:50PM  PRESS DIGEST- Financial Times - Feb 15 Reuters
06:39PM  Berkshire buys Teva, feels IBM blues as Apple becomes top investment Reuters
06:08PM  Buffett Just Messed Things Up for Teva Short-Sellers Bloomberg
06:00PM  Berkshire buys Teva, feels IBM blues as Apple becomes top investment Reuters
05:29PM  Berkshire's Big Bet on Teva May Be Just What Shareholders Need Bloomberg
05:28PM  Warren Buffett's Berkshire Hathaway adds Apple and Teva shares, cuts IBM stake MarketWatch
05:23PM  Warren Buffett's Berkshire Buys Teva, Apple and Slashes IBM GuruFocus.com
05:23PM  Teva Shares Pop After-Hours on News of Berkshire Investment TheStreet.com
04:53PM  Teva Pharma Rockets After Berkshire Hathaway Reportedly Takes Stake Investor's Business Daily
04:21PM  Berkshire takes new 18.9 million-share stake in Teva Phar... CNBC Videos
04:15PM  Teva shares jump 11 percent after Berkshire reports $358 million stake CNBC
09:43AM  Teva Stock Falls as Novartis Brings Another Copaxone Generic Zacks
Feb-13-18 06:02PM  Generic Drugmakers to Dump as Teva's Woes Continue in 2018 Zacks
05:33PM  Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug TheStreet.com
05:12PM  Why Corcept Therapeutics Stock Gained 27.4% in January Motley Fool
03:36PM  Teva Pharmaceutical Industries Ltd -- Moody's says launch of second generic version of Copaxone 40mg is credit negative for Teva Moody's
09:53AM  Novartis gains U.S. approval for delayed MS drug Reuters
09:09AM  Teva shares drop 3% after rival generic product approved and launched MarketWatch
08:31AM  Teva shares plummet 10% after downbeat 2018 guidance MarketWatch
08:10AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Pfizer Inc. ACCESSWIRE
07:44AM  Teva planned for 2nd generic Copaxone to enter market in 2018 Reuters
Feb-12-18 08:26PM  Are Teva Pharmaceutical Industries Limiteds (NYSE:TEVA) Interest Costs Too High? Simply Wall St.
04:29PM  Is Teva Pharma's Restructuring Plan Actually 'More Reasonable'? Investor's Business Daily
04:29PM  Why CSX, Teva Pharmaceutical Industries, and Marathon Oil Jumped Today Motley Fool
11:32AM  Teva Stock Upgraded After Earnings: What You Need to Know Motley Fool
09:52AM  Teva's 'Achievable' 2018 Outlook, Restructuring Plan Trigger Credit Suisse Upgrade Benzinga
09:48AM  Teva Pharmaceutical Industries Ltd (TEVA) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com
08:00AM  Teva Announces U.S. Launch of QVAR® RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol Business Wire
Feb-11-18 12:20PM  Teva stock drops on guidance, manufacturing problems MarketWatch
Feb-10-18 10:30AM  Here's What Teva Pharmaceutical's Saying About Its Future Motley Fool
Feb-09-18 05:33PM  Francisco Garcia Parames Buys 19 Stocks in 4th Quarter GuruFocus.com
03:21PM  Francisco Garcia Parames' Cobas Asset Management Comments on Fourth Quarter 2017 GuruFocus.com
10:39AM  Teva Nailed With S&P Downgrade TheStreet.com
10:26AM  Teva Pharmaceutical Industries Ltd (ADR) Announces the Launch of Generic Equivalents to Syprine SmarterAnalyst
09:50AM  Teva (TEVA) Q4 Earnings Top, Stock Tanks on Weak 2018 View Zacks
09:16AM  Heres Whats Moving Teva Pharmaceutical Industries And Madrigal Pharmaceuticals Market Exclusive
09:00AM  Teva Announces Launch of a Generic Version of Syprine® in the United States Business Wire
08:10AM  Todays Research Reports on Stocks to Watch: Mylan and Teva Pharmaceutical ACCESSWIRE
08:00AM  Will Teva Pharmaceutical's Pain Be Mylan's Gain? Motley Fool
01:16AM  [$$] Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning The Wall Street Journal
Feb-08-18 06:50PM  Teva Shares Tank On Weak Outlook TheStreet.com -10.60%
05:23PM  What Caused Teva Pharmaceutical to Crash 10.6% Today Motley Fool
04:08PM  Teva Beats Quarterly Views But Dives On Weak 2018 Guidance Investor's Business Daily
02:15PM  Teva's Turnarond: Is It Ever Or Never? Forbes
02:00PM  [$$] Teva Shares Plunge After Report of Quarterly Loss, 2018 Forecast The Wall Street Journal
01:09PM  Teva chief reports 'strong progress' in restructuring plan Associated Press
09:27AM  Teva Tumbles, Twitter Soars as Market Seeks Direction Barrons.com
08:36AM  Teva (TEVA) Q4 Earnings & Sales Beat, 2018 View Disappoints Zacks
08:05AM  [$$] Teva Pharmaceutical Loss Widens The Wall Street Journal
07:15AM  Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists Bloomberg
07:00AM  Teva Reports 2017 Full Year and Fourth Quarter Financial Results Business Wire
06:10AM  Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call ACCESSWIRE
Feb-07-18 08:35AM  BDSI reaches settlement with generic drug giant Teva American City Business Journals
Feb-06-18 08:10AM  Teva Pharmaceutical Industries Ltd (ADR): From a Bull to a Bear; Tim Chiang Is Officially Throwing in the Towel SmarterAnalyst
Feb-05-18 04:30PM  These Biotech Stocks Each Dived More Than 20% Is The Sell-Off Overdone? Investor's Business Daily
03:40PM  Why Corcept Therapeutics Incorporated Stock Is Getting Clobbered Today Motley Fool
09:26AM  What's in the Cards for Teva (TEVA) This Earnings Season? Zacks
08:49AM  Corcept's stock tumbles after Teva submits NDA for generic Korlym MarketWatch
07:20AM  Wired News Teva Pharma Announced the Acceptance of Fremanezumabs Marketing Authorization Application by EMA ACCESSWIRE
Feb-02-18 01:16PM  Teva Completes Sale of Women's Health Segment for $703M Zacks
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sabag MarkEVP, Global Human ResourcesFeb 15Sale20.523,00061,56041,517Feb 20 08:31 AM
Sabag MarkEVP, Global Human ResourcesFeb 14Sale18.452,05037,82344,517Feb 20 08:31 AM